The global Nanopore Molecular Sequencing Service market size is predicted to grow from US$ 195 million in 2025 to US$ 256 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.

Nanopore molecular sequencing services were becoming increasingly popular and gaining traction in the genomics and biotechnology fields. Nanopore sequencing is a technology that allows direct, real-time sequencing of DNA and RNA molecules. It offers several advantages over traditional sequencing methods, such as long read lengths, portability, and the ability to sequence native DNA without amplification.

Nanopore sequencing services were experiencing a growing demand due to their applications in various fields, including genomics research, clinical diagnostics, agriculture, and environmental monitoring.

Ongoing research and development efforts were leading to improvements in nanopore sequencing technology, enhancing accuracy and reducing costs, making it more attractive for broader adoption.

Infinity Market Research newest research report, the ?Nanopore Molecular Sequencing Service Industry Forecast? looks at past sales and reviews total world Nanopore Molecular Sequencing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Nanopore Molecular Sequencing Service sales for 2025 through 2031. With Nanopore Molecular Sequencing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nanopore Molecular Sequencing Service industry.

This Insight Report provides a comprehensive analysis of the global Nanopore Molecular Sequencing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nanopore Molecular Sequencing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Nanopore Molecular Sequencing Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nanopore Molecular Sequencing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nanopore Molecular Sequencing Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Nanopore Molecular Sequencing Service market by product type, application, key players and key regions and countries.

Segmentation by Type:

    DNA Sequencing
    RNA Sequencing

Segmentation by Application:

    Laboratory
    Research Institute
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Oxford Nanopore Technologies
    CD Genomics
    BaseClear
    Garvan Institute
    Apical Scientific
    Cold Spring Harbor Laboratory
    ESR
    GeneBay
    Genomedia
    Genotypic Technology
    GenXone
    GSI Lab
    Health GeneTech
    BioTools
    IIT Biotech GmbH
    KeyGene
    MicrobesNG
    Nonacus
    PathoQuest
    Prairie Diagnostic Services
    PT. Genetika Science Indonesia
    Seibutsugiken
    Takara Bio
    Tri-I Biotech
    Novogene
    BGI Genomics